Lodo Therapeutics Corp — Form D/A
Lodo Therapeutics Corp of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2017-01-04. The offering totals $19.9M, of which $19.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-01-04
- Form: D/A
- Accession: 0001662114-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $19.9M
- Amount sold: $19.9M
- Investors: 13
- Date of first sale: 2015-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-254438
Issuer
- Name: Lodo Therapeutics Corp
- CIK: 0001662114
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 430 EAST 29TH STREET, SUITE 845, NEW YORK, NY, 10016
- Phone: (206) 957-7300
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Barbara Johnston Dalton | Director | New York, NY |
| M. Johnston Erwin | Director | New York, NY |
| Steve Gillis | Director | New York, NY |
| THONG LE | Director | Seattle, WA |
| Joel Johnston Marcus | Director | Seattle, WA |
| James Johnston Sullivan | Director | Seattle, WA |
| Misti Johnston Ushio | Director | New York, NY |
| Asish Xavier | Director | South San Francisco, CA |
| THONG LE | Executive Officer | Seattle, WA |
| David Johnston McElligott | Executive Officer | New York, NY |
| David Johnston Pompliano | Executive Officer | New York, NY |
| Lindsay Johnston Rayle | Executive Officer | New York, NY |
| David Johnston Schubert | Executive Officer | New York, NY |
| THONG LE | Promoter | Seattle, WA |
| David Johnston McElligott | Promoter | New York, NY |
| Lindsay Johnston Rayle | Promoter | New York, NY |
| David Johnston Schubert | Promoter | New York, NY |
Other filings by this issuer (1)
More